NEJM Group

NEJM Interviews

Health EN ↓ 945 Folgen

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

Autor

NEJM Group

Kategorie

Health

Podcast-Website

www.nejm.org

Neueste Folge

8. Jul 2026

Wo hören?

Podcasts in der App Replaio Radio Bald verfügbar

Podcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts

Bei Google Play herunterladen Kostenlos installieren Android 5 Mio.+ Downloads · Bewertung 4,8 iOS bald

Folgen

NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States. 07.01.2026

Rachel Sachs is a professor of law at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina and R.E. Sachs. Insurance Coverage and Pricing of Weight-Loss Drugs in the United States. N Engl J Med 2026;394:105-107. S. Gondi, A.S. Kesselheim, and B.N. Rome. Generic Liraglutide — Overlooked but Not Forgotten. N Engl J Me...

NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services. 31.12.2025

Ambar La Forgia is an assistant professor in the Management of Organizations group at the University of California, Berkeley Haas School of Business. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. La Forgia. From Patients to Consumers — The Corporatization of Ambulatory Care. N Engl J Med 2026;394:1-3.

NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend. 17.12.2025

Anne Zink is a lecturer and senior fellow at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.B. Zink, N.C. McCann, and R.P. Walensky. From Crisis to Action — Policy Pathways to Reverse the Rise in Congenital Syphilis. N Engl J Med 2025;393:2388-2391.

NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. 10.12.2025

Reshma Ramachandran is an assistant professor of medicine at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Wallach, J.S. Ross, and R. Ramachandran. Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data. N Engl J Med 2025;393:2284-2286.

NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy. 03.12.2025

Robert Huckman is a professor of business administration at Harvard Business School and a research associate at the National Bureau of Economic Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.M. Cutler and R.S. Huckman. Has Corporatization Met Its Match? The Challenge of Making Money by Keeping People Healthy. N Engl J Med 2025;393:2177-2180.

NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications. 26.11.2025

Nishant Uppal is an instructor in medicine at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Uppal and Z. Song. Venture Capital Investments by U.S. Academic Medical Centers. N Engl J Med 2025;393:2077-2080.

NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine. 19.11.2025

Jane Zhu is an associate professor of medicine in the Division of General Internal Medicine at Oregon Health and Science University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. Zhu and H. Rooke-Ley. Regulating Corporate Control in Health Care — Oregon’s Attempt to Revive the CPOM Doctrine. N Engl J Med 2025;393:1972-1974.

NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders. 12.11.2025

Joshua Barocas is an associate professor of medicine at the University of Colorado Anschutz Medical Campus. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.A. Barocas. The Erosion of Harm Reduction. N Engl J Med 2025;393:1865-1867. B.A. Barsky, A. Caplan-Bricker, and C. Robertson. Religious Liberty as a Shield for Public Health — The Case of Overdose-Preventi...

NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization. 05.11.2025

Yashaswini Singh is an assistant professor of health services, policy, and practice at Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Singh. The Antitrust Antidote to Hospital and Nursing Home Corporatization — Promises and Pitfalls. N Engl J Med 2025;393:1761-1764.

NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease. 22.10.2025

Eberechi Nwogu-Onyemkpa is an assistant professor in the Division of Palliative Medicine at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Nwogu-Onyemkpa and Others. Involving Palliative Care to Improve Outcomes in Sickle Cell Disease. N Engl J Med 2025;393:1553-1556. E. Costa and Others. Thirty Years of Hydroxyurea for S...

NEJM Interview: Michael Liu on a new model that will expand the use of prior authorization in traditional Medicare. 15.10.2025

Michael Liu is a resident physician at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Liu, K.T. Kadakia, and R.K. Wadhera. Proliferation of Prior Authorization in Traditional Medicare — None the WISeR? N Engl J Med 2025;393:1457-1459.

NEJM Interview: Andrew Gabrielson on cuts to the U.S. research agency charged with safeguarding workers’ health. 08.10.2025

Andrew Gabrielson is a pediatric urology fellow at Lurie Children's Hospital of Chicago. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.T. Gabrielson and C. Corwin. Occupational Health and Safety on the Chopping Block — What’s at Stake? N Engl J Med 2025;393:1353-1355.

NEJM Interview: Steven Lipstein on the drivers and the benefits of mergers and consolidation, from the perspective of a health care system leader. 01.10.2025

Steven Lipstein is the former chief executive officer of BJC HealthCare. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S. Lipstein. Insight into Corporate Governance — What Motivates Hospitals and Delivery Systems. N Engl J Med 2025;393:1249-1251.

NEJM Interview: Nancy Krieger on the effects of structural racism on health and health care and the conflation of research on health equity with DEI work. 24.09.2025

Nancy Krieger is a professor of social epidemiology at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Krieger and M.T. Bassett. Structural and Scientific Racism, Science, and Health — Evidence versus Ideology. N Engl J Med 2025;393:1145-1148.

NEJM Interview: John Ayanian on opportunities to study the health and economic effects of Medicaid work requirements and to mitigate their adverse consequences. 17.09.2025

John Ayanian is the director of the Institute for Healthcare Policy and Innovation at the University of Michigan. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.Z. Ayanian. Protecting Medicaid Enrollees with Chronic Conditions amid Work Requirements. N Engl J Med 2025;393:1044-1046.

NEJM Interview: Amanda Janitz on a navigation program aimed at improving cancer outcomes for American Indian and Alaska Native patients. 10.09.2025

Amanda Janitz is an associate professor at the University of Oklahoma Health Sciences Hudson College of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.E. Janitz and Others. Improving Care Coordination for Indigenous Patients with Cancer. N Engl J Med 2025;393:940-942.

NEJM Interview: Darshali Vyas on campaigns to remove race from clinical algorithms. 10.09.2025

Darshali Vyas is a pulmonary and critical care fellow at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.A. Vyas, L.G. Eisenstein, and D.S. Jones. The Race-Correction Debates — Progress, Tensions, and Future Directions. N Engl J Med 2025;393:1029-1036.

NEJM Interview: Amitabh Chandra on why corporatization occurs in health care, when it can succeed, and why it can go wrong. 03.09.2025

Amitabh Chandra is a professor of public policy at the Harvard Kennedy School of Government and a professor of business administration at Harvard Business School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Chandra and M. Shepard. The Corporatization Deal — Health Care, Investors, and the Profit Priority. N Engl J Med 2025;393:833-835.

NEJM Interview: Nicholas Bagley on the Supreme Court’s decision in a case with implications for coverage of preventive services. 20.08.2025

Nicholas Bagley is a professor of law at the University of Michigan Law School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Bagley. Preventive Care at the Supreme Court. N Engl J Med 2025;393:729-731.

NEJM Interview: Tom Frieden on the role of the CDC and current threats to the U.S. public health infrastructure. 13.08.2025

Tom Frieden is the president and chief executive officer of Resolve to Save Lives and former director of the Centers for Disease Control and Prevention. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T.R. Frieden. Dismantling Public Health Infrastructure, Endangering American Lives. N Engl J Med 2025;393:625-627.

NEJM Interview: Nancy Tomes on the century-long transition to a corporate business model in U.S. health care. 06.08.2025

Nancy Tomes is a professor of history at Stony Brook University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Tomes. A Gilded Age for Patients? The Broken Promises of Profit-Driven Medicine. N Engl J Med 2025;393:521-524.

NEJM Interview: Jason Schwartz on changes to the Advisory Committee on Immunization Practices and approaches to sustaining U.S. vaccination efforts. 30.07.2025

Jason Schwartz is an associate professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.L. Schwartz. Revised Recommendations for Covid-19 Vaccines — U.S. Vaccination Policy under Threat. N Engl J Med 2025;393:417-419.

NEJM Interview: Rohan Khazanchi on the gradual but incomplete shift to race-free equations for interpreting pulmonary function tests. 30.07.2025

Watch the NEJM In Studio video of this interview at NEJM.org. Rohan Khazanchi is a research affiliate at the FXB Center for Health and Human Rights at Harvard University and a resident in the Harvard Medicine-Pediatrics Residency Program. Harleen Marwah, the interviewer, is a recent Editorial Fellow at the Journal. R. Khazanchi and Others. Reform and Remedy for Imprecision and Inequity — Ending th...

NEJM Interview: Katie Watson on the interaction of abortion laws with advance-directive and end-of-life laws. 23.07.2025

Katie Watson is a professor of medical education, medical social sciences, and obstetrics and gynecology at the Northwestern University Feinberg School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. K. Watson. Brain Death in Pregnancy — Abortion, Advance-Directive, or End-of-Life Law? N Engl J Med 2025;393:313-315.

NEJM Interview: Peter Marks on the disruption of traditional approaches to establishing Covid-19 vaccine policy in the United States. 16.07.2025

Peter Marks is the former director of the FDA Center for Biologics Evaluation and Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. P. Marks. The Role of Public Health Agencies in Creating Vaccine Policy. N Engl J Med 2025;393:209-211.

Höre den Podcast NEJM Interviews in Replaio

Radio und Podcasts in einer App - kostenlos und ohne Anmeldung. Installiere sie noch heute und verpasse den Start nicht

Bei Google Play herunterladen

Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet